Trubion
Trubion was a publicly held biopharmaceutical company that was focused on creating a pipeline of protein-based therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. Trubion was acquired by Emergent BioSolutions on October 28, 2010. Trubion was established in 1999 in the State of Washington as an early stage development company, and was later reincorporated in October 2002 in the State of Delaware.
Wikipage redirect
primaryTopic
Trubion
Trubion was a publicly held biopharmaceutical company that was focused on creating a pipeline of protein-based therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. Trubion was acquired by Emergent BioSolutions on October 28, 2010. Trubion was established in 1999 in the State of Washington as an early stage development company, and was later reincorporated in October 2002 in the State of Delaware.
has abstract
Trubion was a publicly held bi ...... ded through December 22, 2009.
@en
fate
acquired byEmergent BioSolutions(2010)
@en
founding year
industry
location
type
Link from a Wikipage to an external page
Wikipage page ID
18,649,568
Wikipage revision ID
684,934,304
products
Protein-based therapeutics
subject
comment
Trubion was a publicly held bi ...... 2002 in the State of Delaware.
@en
label
Trubion
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Trubion
@en